Venetoclax Combined With Homoharringtonine and Cytarabine in Induction for AML
Venetoclax Combined With Homoharringtonine and Cytarabine in Induction for AML
Recruiting · NCT05805098 · Registry updated 2023-04-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Venetoclax Combined With Homoharringtonine and Cytarabine in Induction for AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 2 / Phase 3 | 2023-04-07 | NCT05805098 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| The First Affiliated Hospital of Soochow University | 164 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Qiu huiying | Suzhou | China | 2 |